These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8516320)

  • 21. Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.
    Taniguchi K; Petersson M; Höglund P; Kiessling R; Klein G; Kärre K
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3405-9. PubMed ID: 3106968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-induced guanylate-binding proteins: mapping of the murine Gbp-1 locus to chromosome 3.
    Prochazka M; Staeheli P; Holmes RS; Haller O
    Virology; 1985 Sep; 145(2):273-9. PubMed ID: 3927587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed hypersensitivity to Newcastle disease virus in high and low interferon-producing mice.
    De Maeyer E; De Maeyer-Guignard J
    J Immunol; 1983 May; 130(5):2392-6. PubMed ID: 6833760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced tumor development in mice lacking a functional type I interferon receptor.
    Picaud S; Bardot B; De Maeyer E; Seif I
    J Interferon Cytokine Res; 2002 Apr; 22(4):457-62. PubMed ID: 12034028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
    Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
    Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice.
    McKenna SD; Vergilis K; Arulanandam AR; Weiser WY; Nabioullin R; Tepper MA
    J Interferon Cytokine Res; 2004 Feb; 24(2):119-29. PubMed ID: 14980076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer.
    Patel S; Turner PR; Stubberfield C; Barry E; Rohlff CR; Stamps A; McKenzie E; Young K; Tyson K; Terrett J; Box G; Eccles S; Page MJ
    Int J Cancer; 2002 Feb; 97(4):416-24. PubMed ID: 11802201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocytosis of hyaluronidase-1 by the liver.
    Gasingirwa MC; Thirion J; Mertens-Strijthagen J; Wattiaux-De Coninck S; Flamion B; Wattiaux R; Jadot M
    Biochem J; 2010 Sep; 430(2):305-13. PubMed ID: 20572808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
    Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes.
    Li J; Liu Y; Xie C; Zhu J; Kreska D; Morel L; Mohan C
    Arthritis Rheum; 2005 Oct; 52(10):3063-72. PubMed ID: 16200585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
    Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
    J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant interferon-beta ser on primary human tumor colony-forming units.
    Von Hoff DD; Huong AM
    J Interferon Res; 1988 Dec; 8(6):813-20. PubMed ID: 3230332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.
    Krepler C; Certa U; Wacheck V; Jansen B; Wolff K; Pehamberger H
    J Invest Dermatol; 2004 Oct; 123(4):664-9. PubMed ID: 15373770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
    Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J
    Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.
    Ren C; Kumar S; Chanda D; Chen J; Mountz JD; Ponnazhagan S
    Stem Cells; 2008 Sep; 26(9):2332-8. PubMed ID: 18617688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse liver lysosomes contain enzymatically active processed forms of Hyal-1.
    Boonen M; Puissant E; Gilis F; Flamion B; Jadot M
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1155-60. PubMed ID: 24667601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
    Fraioli M; Wu JM
    J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.